Dr. Hakam Singh's soy and testosterone claims, fact-checked
Quick answer
The video's caption correctly identifies that soy phytoestrogens (primarily genistein and daidzein) are structurally distinct from endogenous estradiol and bind to estrogen receptors with significantly lower affinity. Current evidence does not support clinically meaningful testosterone suppression from typical dietary soy intake in healthy men. Men actively managing hormone levels through TRT should discuss high-dose soy supplementation with their prescriber, as individualized estrogen metabolism may introduce variables not captured in population-level data.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @drhakamsingh actually say?
Honestly, this one is hard to parse. The video's caption makes a clear, defensible claim: soy phytoestrogens are not human estrogen, and soy is safe for men. That message is solid. But the actual spoken transcript is largely incoherent, mixing fragmented English with what appears to be Punjabi, and much of it does not form complete medical claims. At one point the creator says the "female hormone is the testosterone hormone," which is either a translation error or a genuine misstatement. The second half of the transcript appears to discuss protein content of soy products, tofu, and soy chunks. Given the disconnect between caption and transcript, the visual content was probably carrying most of the argument here.
Does the science back this up?
On the core claim, yes, the caption is largely right. The evidence does not support the idea that normal dietary soy intake suppresses testosterone in healthy men. Multiple controlled trials and reviews have looked at this directly. Messina (2010, Fertility and Sterility) reviewed 32 studies and found that neither soy foods nor isoflavone supplements altered testosterone or estrogen levels in men. A more recent meta-analysis by Reed et al. (2021, Reproductive Toxicology) examined 41 studies and again found no significant effect on total testosterone, free testosterone, or estrogen levels at normal dietary intake levels. The phytoestrogen argument, that isoflavones like genistein and daidzein bind weakly to estrogen receptors, is real biology, but binding affinity is orders of magnitude lower than endogenous estradiol. Context matters enormously here.
What did they get wrong (or right)?
The caption got the main point right: phytoestrogens are not human estrogen, and calling soy a hormone disruptor for men eating normal portions is not supported by the evidence. Credit where it is due. But the spoken content contains at least one flat-out error. The phrase "the female hormone is the testosterone hormone" is factually wrong regardless of interpretation. Testosterone is the primary androgen, not a female hormone in the physiological sense, though all sexes produce it. There are also two important caveats the video skips entirely. First, extremely high isoflavone intake, well beyond typical dietary consumption, has been linked to hormonal effects in case reports (Martinez and Lewi, 2008, Endocrine Practice). Second, men with pre-existing hypogonadism or on TRT may metabolize estrogen differently, and that context deserves mention when your account is categorized under TRT and hormone optimization.
What should you actually know?
If you are eating tofu a few times a week or adding soy protein to your shakes, the data says you are almost certainly fine. A standard serving of soy foods delivers around 25-50mg of isoflavones. Population-level evidence from high-soy-consuming countries like Japan does not show elevated rates of hypogonadism or gynecomastia. However, the case is not completely closed for every population. Men with compromised thyroid function may absorb thyroid medication less efficiently if taken alongside soy, per Messina and Redmond (2006, Thyroid). Men on TRT who are closely managing their estrogen-to-testosterone ratio might want to discuss high soy intake with their prescribing clinician, not because soy is dangerous, but because personalized context matters. The "soy boy" myth is bro-science. The nuance around high-dose supplementation or specific clinical profiles is not.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Dr. Hakam Singh's soy and testosterone claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Dr. Hakam Singh's soy and testosterone claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video's caption correctly identifies that soy phytoestrogens (primarily genistein and daidzein) are structurally distinct from endogenous estradiol and bind to estrogen receptors with significantly lower affinity.
FormBlends verdict
The video's caption correctly identifies that soy phytoestrogens (primarily genistein and daidzein) are structurally distinct from endogenous estradiol and bind to estrogen receptors with significantly lower affinity. Current evidence does not support clinically meaningful testosterone suppression from typical dietary soy intake in healthy men. Men actively managing hormone levels through TRT should discuss high-dose soy supplementation with their prescriber, as individualized estrogen metabolism may introduce variables not captured in population-level data.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video's caption correctly identifies that soy phytoestrogens (primarily genistein and daidzein) are structurally distinct from endogenous estradiol and bind to estrogen receptors with significantly lower affinity. Current evidence does not support clinically meaningful testosterone suppression from typical dietary soy intake in healthy men. Men actively managing hormone levels through TRT should discuss high-dose soy supplementation with their prescriber, as individualized estrogen metabolism may introduce variables not captured in population-level data.
- Reed et al. (2021, Reproductive Toxicology) analyzed 41 studies and found no significant impact of soy or isoflavones on total testosterone, free testosterone, or estradiol in men at normal dietary intake.
- Isoflavones like genistein bind to estrogen receptors at roughly 0.1% the affinity of estradiol, making direct hormonal equivalency biologically implausible at food-level doses.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Reed et al. (2021, Reproductive Toxicology) analyzed 41 studies and found no significant impact of soy or isoflavones on total testosterone, free testosterone, or estradiol in men at normal dietary intake.
- Isoflavones like genistein bind to estrogen receptors at roughly 0.1% the affinity of estradiol, making direct hormonal equivalency biologically implausible at food-level doses.
- A typical soy-containing meal delivers 25-50mg of isoflavones; most clinical trials showing no hormonal effect used doses in this range, so portion size matters for interpreting the evidence.
- Case reports of gynecomastia linked to soy involve isoflavone intake far exceeding dietary norms, often from concentrated supplement use, not tofu or soy milk (Martinez and Lewi, 2008, Endocrine Practice).
- Men on TRT should inform their prescriber about high soy supplementation, not because soy is dangerous, but because estrogen management in TRT protocols is individualized and dietary inputs can shift the picture.
- Population data from Japan, where soy consumption is among the highest globally, does not show elevated rates of hypogonadism or gynecomastia in men, offering a useful real-world benchmark.
- The spoken transcript in this video contains factual errors and incoherent passages; the caption's message is more defensible than what was verbally communicated, which matters for how much clinical weight to assign the content.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Hakam Singh · Instagram creator
67.8K views on this video
Still afraid of the “Soy Boy” myth? 🥛🧬 Let’s put the “man boob” myth to rest with some actual biology. Spoiler: Your tofu isn’t plotting against your testosterone. Phytoestrogens are NOT human oestr
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Hakam Singh, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.